Multiomic study maps microsatellite-stable colorectal cancer biology and drug targets
Start here
A study published in Cancer Cell integrated multiomic, single-cell, and clinical data from roughly 2,000 microsatellite-stable colorectal cancers — about 4,500 multiomic profiles and 195,246 cells or nuclei — to define the disease's underlying biology. Led by Sadanandam and colleagues, the work identified replication stress, right-sided tumor location, glutaminolysis, and MYC-E2F epigenetic programs as key biological features of these tumors. On the therapeutic side, the analysis pinpointed inhibition of FAK, PDK1/2, and the proteasome, each combined with trametinib, as potential treatment strategies. The findings are published; preclinical and clinical validation of the proposed combinations has not yet been established in this coverage.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- cell.comPickMultiomic characterization of microsatellite-stable colorectal cancer reveals distinct biology and targetable vulnerabilities
Sadanandam et al. integrated multiomic, single-cell, and clinical data from about 2,000 microsatellite-stable colorectal cancers (about 4,500 multiomic profiles, 195,246 cells/nuclei). The analyses identify replication stress, right-sided tumors, glutaminolysis, and MYC-E2F epigenetic programs as key biological features, and point to FAK, PDK1/2, and proteasome inhibition combined with trametinib as potential therapeutic strategies.
Heat trend for this story
Heat now 6·Peak in the comparable set 6 (Oct 23 00:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.